Growth Hormone Releasing Hormone Analog to Improve Nonalcoholic Fatty Liver Disease and Associated Cardiovascular Risk

Clinical trial NCT03375788 · COMPLETED

Trial details

NCT number: NCT03375788
Sponsor: Massachusetts General Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Alcoholic Fatty Liver Disease Obesity Obesity, Abdominal Liver Fat Fatty Liver

Start date: 2019-01-17
Primary completion: 2024-07-10
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.